DUBLIN & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--dabl Limited, a provider of centralized ambulatory blood pressure measurement (ABPM) services, and Quintiles, the world’s leading global biopharmaceutical services company, today announced a strategic alliance that significantly enhances Quintiles’ suite of offerings in cardiovascular safety assessment. Through the alliance, Quintiles’ customers worldwide will have access to dabl’s round-the-clock ABPM services to enhance the safety and efficacy of global clinical trials across the entire trial lifecycle.
